Related content

Continuous expression of CD83 on activated human CD4+ T cells is correlated with their differentiation into induced regulatory T cells

By            

Molecular Medicine Reports, Vol. 12, Iss. 3, 2015-01 ,pp. : 3309-3314

Spandidos Publications

Access to resources Recommend Favorite

Telomere length of in vivo expanded CD4⁺CD25⁺ regulatory T-cells is preserved in cancer patients

By Wolf Dominik   Rumpold Holger   Koppelstätter Christian   Gastl Guenther   Steurer Michael   Mayer Gert   Gunsilius Eberhard   Tilg Herbert   Wolf Anna  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 10, 2006-10 ,pp. : 1198-1208

Springer Publishing Company

Access to resources Recommend Favorite

Depletion of CD4⁺CD25⁺ Regulatory T Cells Promotes a Tumor-Specific Immune Response in Pancreas Cancer–Bearing Mice

By Viehl Carsten   Moore Todd   Liyanage Udaya   Frey Daniel   Ehlers Jesmin   Eberlein Timothy   Goedegebuure Peter   Linehan David  

Annals of Surgical Oncology, Vol. 13, Iss. 9, 2006-09 ,pp. : 1252-1258

Springer Publishing Company

Access to resources Recommend Favorite

Functional inactivation of CD4+CD25 high regulatory T cells using low dose human/mouse chimeric anti-CD25 monoclonal antibody enhanced lymphokine-activated killer cells activity

By Okita Riki  

Targeted Oncology, Vol. 3, Iss. 4, 2008-10 ,pp. : 227-234

Springer Publishing Company

Access to resources Recommend Favorite

Metronomic cyclophosphamide regimen selectively depletes CD4⁺CD25⁺ regulatory T cells and restores T and NK effector functions in end stage cancer patients

By Ghiringhelli François   Menard Cedric   Puig Pierre   Ladoire Sylvain   Roux Stephan   Martin François   Solary Eric   Le Cesne Axel   Zitvogel Laurence   Chauffert Bruno  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 5, 2007-05 ,pp. : 641-648

Springer Publishing Company

Access to resources Recommend Favorite